Cargando…
Development of Novel Arginase Inhibitors for Therapy of Endothelial Dysfunction
Endothelial dysfunction and resulting vascular pathology have been identified as an early hallmark of multiple diseases, including diabetes mellitus. One of the major contributors to endothelial dysfunction is a decrease in nitric oxide (NO) bioavailability, impaired NO signaling, and an increase in...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774993/ https://www.ncbi.nlm.nih.gov/pubmed/24062745 http://dx.doi.org/10.3389/fimmu.2013.00278 |